Karen Andersen, CFA, is a healthcare strategist for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She is r ...

Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Moderna Inc. reported a wider-than-expected fourth-quarter loss on Wednesday, as the biotech company grapples with declining COVID-19 vaccine sales and ongoing restructuring costs. The vaccine maker ...

Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 59 tables and 54 figures, this 141-page report ?Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 111 tables and 87 figures, this 211-page report ?Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, ...

A chemical engineering professor at the University of Cincinnati is developing new ways to deliver treatments for infectious ...

Moderna (NASDAQ: NASDAQ: MRNA) stock declined 4.9% and BioNTech SE (NASDAQ: NASDAQ: BNTX) shares fell 1.5% following the ...

Construction is now complete on the Moderna Innovation and Technology Centre (MITC), the pharma firm’s new research, ...

The vaccine is being developed by pharmaceutical firm Moderna, which has recruited 25,000 volunteers worldwide, including 2,500 in the UK, for the trial. Like Moderna's vaccine used in the Covid ...